Research License Period definition

Research License Period means, on a Research Antigen-by-Research Antigen basis, the period commencing on the date that Medarex notifies Celldex of the availability of an antigen pursuant to Section 3.2 (the “Notification Date”), and ending on the earlier of (i) twelve (12) months after the Notification Date, or if extended pursuant to Section 3.4.2, the expiration of any such extension(s), or (ii) when Celldex has taken an Exclusive Commercial License with respect to the particular Research Antigen pursuant to Section 4.3, or (iii) the termination of the Agreement.
Sample 1Sample 2Sample 3
Research License Period means, other than as provided in Section 4.5.2, for each Designated Antigen, the earlier of (a) [***], or (b) [***].
Sample 1
Research License Period means, other than as provided in Section 4.5.2, for each Designated Antigen, the earlier of (a) [ * ] , or (b) [ * ] . “Royalty Reports” has the meaning set forth in Section 11.9. “Royalty Term” means, on a Product-by-Product and country-by-country basis, the period commencing on the First Commercial Sale of a Product and ending upon [ * ] : (a) [ * ] ; or (b) (x) [ * ] , or (y) [ * ]
Sample 1

Examples of Research License Period in a sentence

  • The parties acknowledge and agree that Celldex shall not owe any payment for the initial twelve (12) months of a Research License Period with respect to each Research Antigen.

  • At any time during the Research License Period with respect to a particular Research Antigen, Celldex may provide written notice to Medarex that it wishes to acquire an Exclusive Commercial License to an Antibody raised against such Research Antigen and to Products containing such Antibody.

  • Upon expiration of the Research License Period for a Research Antigen, the corresponding Research License granted hereunder shall expire.

  • If Celldex elects to obtain a Research License from Medarex pursuant to Section 3.1 with respect to a particular Antigen, there shall be no license fee for the initial Research License Period for such Antigen.

  • The initial Research License Period for a particular Research Antigen shall commence on the date that Medarex notifies Celldex that a particular Research Antigen is available for licensing by Celldex pursuant to Section 3.2 and shall expire twelve (12) months later.

  • Upon expiration of the Research License Period for a given Research Antigen, the applicable Research License shall terminate.

  • If Celldex elects to extend the Research License Period for a particular Research Antigen pursuant to Section 3.4.2, then concurrently with its notice that Celldex wishes to extend the Research License Period for such Research Antigen, Celldex shall pay to Medarex a non-refundable, non-creditable license fee of [*****] for each twelve (12) month extension.

  • The Research License Period can be extended on a case-by-case basis with the agreement of the CSC only and a maximum of up to [*].

  • Upon expiration of the Research License Period, the corresponding Research License granted hereunder shall expire.

  • If Genmab elects to extend the Research License Period for either a [***] Research Antigen or an [***] Research Antigen pursuant to Section 15.3.2(a) or 15.3.2(b), Genmab shall pay to Medarex [***] for each [***] extension per [***] Research Antigen or [***] Research Antigen.

Related to Research License Period

  • License Period means the period beginning from the Commencement Date and ending on the Termination Date.

  • Research License means a nontransferable, nonexclusive license to make and to use the Licensed Products or the Licensed Processes as defined by the Licensed Patent Rights for purposes of research and not for purposes of commercial manufacture or distribution or in lieu of purchase.

  • License Term means the duration of a License as specified in the Order.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Collaboration Term has the meaning set forth in Section 2.1(h).

  • Research Term has the meaning set forth in Section 3.2.

  • Research Period means the research period as described in the Commissioned Research Plan. In accordance with the provisions of this Agreement, in the event that the Agreement ended prior to the completion date of the research originally set, the date the Agreement ends shall be read as the research period.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • License Key means a unique key-code that enables Licensee to run Software subject to the obtained User Pack.

  • Licensed Field means [***].

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Research Program has the meaning set forth in Section 3.1.

  • Licensed Field of Use means all fields.

  • Exclusivity Period shall have the meaning set forth in Section 6.11.

  • Licensed Programs means, collectively, NeoSystems’ and any Third Party Vendor computer software programs to be provided to Client for use on certain hardware on Client’s premises or a third party’s premises as set forth in an Agreement. The Licensed Programs shall include any fixes, work-arounds, updates, revisions, modifications, enhancements and any derivative works that are provided to Client by NeoSystems under an Agreement.

  • Licensed Fields of Use means the fields of use identified in Appendix B.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Collaboration has the meaning set forth in Section 2.1.

  • Sublicense Agreement means any agreement or arrangement pursuant to which Licensee (or an Affiliate or Sublicensee) grants to any third party any of the license rights granted to the Licensee under the Agreement.

  • Royalty Term means, on a country-by-country basis, the period commencing on the First Commercial Sale of a Licensed Product in a country and ending on the latest of (a) ** thereafter, (b) expiration of the last-to-expire Valid Claim of a Licensed Patent that Covers the composition of matter of the Licensed Product in the country in which it is sold, or (c) the expiration of all Regulatory Exclusivity Rights with respect to such Licensed Product in the country in which it is sold.

  • Licensee Technology means the Licensee Know-How and Licensee Patents.

  • Development Period means the period from the date of this Agreement until the Appointed Date;

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Licensed Technology means the Licensed Patents and the Licensed Know-How.